Convenient Preparation of <sup>18</sup>F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 99, doi. 10.3390/ph10040099
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2017 AND VI 10 AND IP 4
Results: 21
1
2
Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 98, doi. 10.3390/ph10040098
- By:
- Publication type:
- Article
3
25th Conference of GP2A.
- Published in:
- 2017
- By:
- Publication type:
- Conference Paper/Materials
4
Biodegradable Scaffolds for Bone Regeneration Combined with Drug-Delivery Systems in Osteomyelitis Therapy.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 96, doi. 10.3390/ph10040096
- By:
- Publication type:
- Article
5
Microglia M2A Polarization as Potential Link between Food Allergy and Autism Spectrum Disorders.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 95, doi. 10.3390/ph10040095
- By:
- Publication type:
- Article
6
31ièmes Journées Franco-Belges de Pharmacochimie: Meeting Report.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 94, doi. 10.3390/ph10040094
- By:
- Publication type:
- Article
7
Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 93, doi. 10.3390/ph10040093
- By:
- Publication type:
- Article
8
A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 91, doi. 10.3390/ph10040091
- By:
- Publication type:
- Article
9
Propagation of Fibrillar Structural Forms in Proteins Stopped by Naturally Occurring Short Polypeptide Chain Fragments.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 89, doi. 10.3390/ph10040089
- By:
- Publication type:
- Article
10
Amorphous Solid Dispersion of Epigallocatechin Gallate for Enhanced Physical Stability and Controlled Release.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 88, doi. 10.3390/ph10040088
- By:
- Publication type:
- Article
11
Synthesis and In Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 87, doi. 10.3390/ph10040087
- By:
- Publication type:
- Article
12
Neurochemical Changes and c-Fos Mapping in the Brain after Carisbamate Treatment of Rats Subjected to Lithium–Pilocarpine-Induced Status Epilepticus.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 85, doi. 10.3390/ph10040085
- By:
- Publication type:
- Article
13
Essential Oils and Antifungal Activity.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 86, doi. 10.3390/ph10040086
- By:
- Publication type:
- Article
14
PARP Inhibition by Flavonoids Induced Selective Cell Killing to BRCA2-Deficient Cells.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 80, doi. 10.3390/ph10040080
- By:
- Publication type:
- Article
15
Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 83, doi. 10.3390/ph10040083
- By:
- Publication type:
- Article
16
Electrographic Changes Accompanying Recurrent Seizures under Ketogenic Diet Treatment.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 82, doi. 10.3390/ph10040082
- By:
- Publication type:
- Article
17
Molecular Docking and 3D-Pharmacophore Modeling to Study the Interactions of Chalcone Derivatives with Estrogen Receptor Alpha.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 81, doi. 10.3390/ph10040081
- By:
- Publication type:
- Article
18
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 79, doi. 10.3390/ph10040079
- By:
- Publication type:
- Article
19
Acorenone B: AChE and BChE Inhibitor as a Major Compound of the Essential Oil Distilled from the Ecuadorian Species Niphogeton dissecta (Benth.) J.F. Macbr.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 84, doi. 10.3390/ph10040084
- By:
- Publication type:
- Article
20
Heparin Mimetics: Their Therapeutic Potential.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 78, doi. 10.3390/ph10040078
- By:
- Publication type:
- Article
21
Procedures for the GMP-Compliant Production and Quality Control of [<sup>18</sup>F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 4, p. 77, doi. 10.3390/ph10040077
- By:
- Publication type:
- Article